Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Leukemia 39Myelodysplastic Syndromes 29Congenital Abnormalities 12Lymphoma, Non-Hodgkin 9Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Biphenotypic, Acute 8Recurrence 7Lymphoma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Hematologic Neoplasms 7Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Leukemia, Promyelocytic, Acute 4Leukemia, Myeloid, Accelerated Phase 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Neoplasms 3Multiple Myeloma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Juvenile 3Graft vs Host Disease 3Burkitt Lymphoma 3

Interventions

dacetuzumab 6blinatumomab 6Rituximab 4Epoetin Alfa 4Lenalidomide 3Dexamethasone 3Darbepoetin alfa 3Cyclophosphamide 3Bortezomib 3Therapeutics 2Everolimus 2Early Intervention, Educational 2Alemtuzumab 2venetoclax 1vandetanib 1tirbanibulin 1tetulomab tetraxetan lu-177 1ponatinib 1plerixafor 1pembrolizumab 1pegaspargase 1isatuximab 1imetelstat 1ibrutinib 1fludarabine 1ficlatuzumab 1ferrous sulfate 1ferric gluconate 1ferric carboxymaltose 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoproliferative Disorders × Clofarabine × Clear all
NCT00028418 2015-03-25

Clofarabine in Chronic Lymphocytic Leukemia

FDA Office of Orphan Products Development

Phase 1 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡